Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients
eLife · 09.03.2023 · 12
DOI: 10.7554/elife.83116 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift eLife, online erschienen am 09.03.2023. Verfasst von Peter Bruun-Rasmussen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Innovation Fund Denmark.
Abstract (Originalsprache)
Background
Whether natural selection may have attributed to the observed blood group frequency differences between populations remains debatable. The ABO system has been associated with several diseases and recently also with susceptibility to COVID-19 infection. Associative studies of the RhD system and diseases are sparser. A large disease-wide risk analysis may further elucidate the relationship between the ABO/RhD blood groups and disease incidence.
Methods
We performed a systematic log-linear quasi-Poisson regression analysis of the ABO/RhD blood groups across 1,312 phecode diagnoses. Unlike prior studies, we determined the incidence rate ratio for each individual ABO blood group relative to all other ABO blood groups as opposed to using blood group O as the reference. Moreover, we used up to 41 years of nationwide Danish follow-up data, and a disease categorization scheme specifically developed for diagnosis-wide analysis. Further, we determined associations between the ABO/RhD blood groups and the age at the first diagnosis. Estimates were adjusted for multiple testing.
Results
The retrospective cohort included 482,914 Danish patients (60.4% females). The incidence rate ratios (IRRs) of 101 phecodes were found statistically significant between the ABO blood groups, while the IRRs of 28 phecodes were found statistically significant for the RhD blood group. The associations included cancers and musculoskeletal-, genitourinary-, endocrinal-, infectious-, cardiovascular-, and gastrointestinal diseases.
Conclusions
We found associations of disease-wide susceptibility differences between the blood groups of the ABO and RhD systems, including cancer of the tongue, monocytic leukemia, cervical cancer, osteoarthrosis, asthma, and HIV- and hepatitis B infection. We found marginal evidence of associations between the blood groups and the age at first diagnosis. Funding: Novo Nordisk Foundation and the Innovation Fund Denmark
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
- Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Peter Bruun-Rasmussen, Morten Hanefeld Dziegiel, Søren Brunak
Förderung
- Novo Nordisk Fonden
- Innovation Fund Denmark
Zitieren
APA
Bruun-Rasmussen, P., Hanefeld Dziegiel, M., Banasik, K., Johansson, P. I., & Brunak, S. (2023). Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients. eLife, 12. https://doi.org/10.7554/elife.83116
Vancouver
Bruun-Rasmussen P, Hanefeld Dziegiel M, Banasik K, Johansson PI, Brunak S. Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients. eLife. 2023;12. doi:10.7554/elife.83116
BibTeX
@article{BruunRasmussen2023,
author = {Bruun-Rasmussen, Peter and Hanefeld Dziegiel, Morten and Banasik, Karina and Johansson, Pär Ingemar and Brunak, Søren},
title = {Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.83116}
}
EUVIMED